Investor Type | Firm |
Industries | BioTech • Life Science |
Investing | United States |
Investment Range | $40,780,000 - $40,780,000 |
Hunt BioVentures is a venture capital firm located in Dallas, Texas, that focuses on providing capital to young private and public companies within the pharmaceutical, medical device, and agricultural biotech sectors. Founded in 2001, the firm operates as part of the wider Hunt family of companies and builds on a legacy of diverse business activities ranging from oil and gas exploration and production, refining, LNG, power, real estate, investments, ranching, and infrastructure, which all fall under its parent entity, Hunt Consolidated, Inc. With a commitment to supporting innovation and development in the life sciences, Hunt BioVentures invests mainly in enterprises that are in the clinical development stage but also extends its reach to pre-clinical opportunities, adhering to investment amounts that can be as high as $40,780,000. These substantial investments underline the firm's dedication to fostering significant advancements in biotechnology and life science industries, driving progress that can lead to groundbreaking treatments and technologies. Hunt BioVentures' investment philosophy is rooted in the rich heritage and principles of the entire Hunt family of businesses, which emphasize integrity, respect, humility, and community. The firm leverages the diverse expertise and resources of the Hunt companies while focusing specifically on the biotech sector to create value for the entities it invests in and contribute positively to broader societal health outcomes.